Chloroquine (CQ) is a cost effective antimalarial drug with a relatively good safety profile (or therapeutic index). However, CQ is no longer used alone to treat patients with Plasmodium falciparum due to the emergence and spread of CQ-resistant strains, also reported for P. vivax. Despite CQ resistance, novel drug candidates based on the structure of CQ continue to be considered, as in the present work. One CQ analog was synthesized as monoquinoline (MAQ) and compared with a previously synthesized bisquinoline (BAQ), both tested against P. falciparum in vitro and against P. berghei in mice, then evaluated in vitro for their cytotoxicity and ability to inhibit hemozoin formation. Their interactions with residues present in the NADH binding site of P falciparum lactate dehydrogenase were evaluated using docking analysis software. Both compounds were active in the nanomolar range evaluated through the HRPII and hypoxanthine tests. MAQ and BAQ derivatives were not toxic, and both compounds significantly inhibited hemozoin formation, in a dose-dependent manner. MAQ had a higher selectivity index than BAQ and both compounds were weak PfLDH inhibitors, a result previously reported also for CQ. Taken together, the two CQ analogues represent promising molecules which seem to act in a crucial point for the parasite, inhibiting hemozoin formation.
References
[1]
WHO (2010) World Malaria Report 2010. Available at: http://www.who.int/malaria/world_malaria？_report_2010/worldmalariareport2010.pdf. Accessed: march/2011.
[2]
de Ridder S, van der Kooy F, Verpoorte R (2008) Artemisia annua as a self-reliant treatment for malaria in developing countries. J Ethnopharmacol 120: 302–314.
Baird JK (2004) Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother 48: 4075–4083.
[5]
de Santana Filho FS, Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, et al. (2007) Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis. 13: 1125–1126.
[6]
Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, et al. (2008) Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med 5: e128.
[7]
Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, et al. (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455–467.
[8]
Lin JT, Juliano JJ, Wongsrichanalai C (2010) Drug-Resistant Malaria: The Era of ACT. Curr Infect Dis Rep 12: 165–173.
[9]
Rosenthal PJ (2003) Antimalarial drug discovery: old and new approaches. J Exp Biol 206: 3735–3744.
[10]
Krettli AU, Adebayo JO, Krettli LG (2009) Testing of natural products and synthetic molecules aiming at new antimalarials. Curr Drug Targets 10: 261–270.
[11]
Enserink M (2010) If artemisinin drugs fail, what's plan B? Science 328: 846.
[12]
Krettli , AU (2009) Antimalarial drug discovery: screening of Brazilian medicinal plants and purifi ed compounds. Expert Opin. Drug Discov 4: 95–108.
[13]
Cunico W, Cechinel C, Bonacorso H, Martins M, Zanatta N, et al. (2006) Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-ch？loroquineanalogues. Bioorg Med Chem Lett 16: 649–653.
[14]
de Pilla Varotti F, Botelho A, Andrade A, de Paula R, Fagundes E, et al. (2008) Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate. Antimicrob Agents Chemother 52: 3868–3874.
[15]
Ryckebusch A, Debreu-Fontaine MA, Mouray E, Grellier P, Sergheraert C, et al. (2005) Synthesis and antimalarial evaluation of new N1-(7-chloro-4-quinolyl)-1,4-bis(3-amino？propyl)piperazinederivatives. Bioorg Med Chem Lett 15: 297–302.
[16]
Yearick K, Ekoue-Kovi K, Iwaniuk DP, Natarajan JK, Alumasa J, et al. (2008) Overcoming drug resistance to heme-targeted antimalarials by systematic side chain variation of 7-chloro-4-aminoquinolines. J Med Chem 51: 1995–1998.
[17]
Ekoue-Kovi K, Yearick K, Iwaniuk DP, Natarajan JK, Alumasa J, et al. (2009) Synthesis and antimalarial activity of new 4-amino-7-chloroquinolyl amides, sulfonamides, ureas and thioureas. Bioorg Med Chem 17: 270–283.
[18]
Andrews S, Burgess SJ, Skaalrud D, Kelly JX, Peyton DH (2010) Reversal agent and linker variants of reversed chloroquines: activities against Plasmodium falciparum. J Med Chem 53: 916–919.
[19]
Blackie MA, Yardley V, Chibale K (2010) Synthesis and evaluation of phenylequine for antimalarial activity in vitro and in vivo. Bioorg Med Chem Lett 20: 1078–1080.
[20]
Girault S, Grellier P, Berecibar A, Maes L, Lemière P, et al. (2001) Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with linear or cyclic amino linkers. J Med Chem 44: 1658–1665.
[21]
Carey FA, Sundberg RJ (1990) Advanced Organic Chemistry Part B: Reactions and Synthesis, 3rd Ed, Plenum, New York pg 597:
[22]
Dorn A, Vippagunta S, Matile H, Jaquet C, Vennerstrom J, et al. (1998) An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol 55: 727–736.
[23]
Portela C, Afonso CM, Pinto MM, Ramos MJ (2003) Receptor-drug association studies in the inhibition of the hematin aggregation process of malaria. FEBS Lett 547: 217–222.
[24]
Menting J, Tilley L, Deady L, Ng K, Simpson R, et al. (1997) The antimalarial drug, chloroquine, interacts with lactate dehydrogenase from Plasmodium falciparum. Mol Biochem Parasitol 88: 215–224.
[25]
Penna-Coutinho J, Cortopassi WA, Oliveira AA, Fran？a TC, Krettli AU (2011) Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies. PLoS One 6: e21237.
[26]
Dios AC, Casabianca , LB , Kosar A, Roepe PD (2004) Structure of the Amodiaquine-FFIX Oxo dimer solution complex at atomic resolution. Inorg Chem 43: 8078–8084.
[27]
Vippagunta SR, Dorn A, Matile H, Bhattacharjee AK, Karle JM, et al. (1999) Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth. J Med Chem 42: 4630–4639.
Cortopassi WA, Oliveira AA, Guimar？es AP, Rennó MN, Krettli AU, et al. (2011) Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase. J Biomol Struct Dyn 29: 207–218.
[30]
Read J, Wilkinson K, Tranter R, Sessions R, Brady R (1999) Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase. J Biol Chem 274: 10213–10218.
[31]
Chellan P, Nasser S, Vivas L, Chibale K, Smith GS (2010) Cyclopalladated complexes containing tridentate thiosemicarbazone ligands of biological significance: Synthesis, structure and antimalarial activity. J.Organomet. Chem. 695: 2225–2232.
[32]
Sánchez-Delgado RA, Navarro M, Pérez H, Urbina JA (1996) Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. J Med Chem 39: 1095–1099.
[33]
Navarro M, Pérez H, Sánchez-Delgado RA (1997) Toward a novel metal-based chemotherapy against tropical diseases. 3. Synthesis and antimalarial activity in vitro and in vivo of the new gold-chloroquine complex [Au(PPh3)(CQ)]PF6. J Med Chem 40: 1937–1939.
[34]
Gasser G, Ott I, Metzler-Nolte N (2011) Organometallic anticancer compounds. J Med Chem 54: 3–25.
[35]
Galanski M, Jakupec MA, Keppler BK (2005) Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches. Curr Med Chem 12: 2075–2094.
[36]
Gabbiani C, Messori L, Cinellu MA, Casini A, Mura P, et al. (2009) Outstanding plasmodicidal properties within a small panel of metallic compounds: Hints for the development of new metal-based antimalarials. J Inorg Biochem 103: 310–312.
[37]
Navarro M, Vásquez F, Sánchez-Delgado RA, Pérez H, Sinou V, et al. (2004) Toward a novel metal-based chemotherapy against tropical diseases. 7. Synthesis and in vitro antimalarial activity of new gold-chloroquine complexes. J Med Chem 47: 5204–5209.
[38]
Ajibade P A, Kolawole GA, O'Brien P, Helliwell M (2006) Synthesis and characterization of Ni(II), Pd(II) and Pt(II) complexes of 2,4-diamino-5-(3, 4, 5-trimethoxybenzyl) pyrimidine complexes. J Coord Chem 59: 1621–1628.
[39]
Musonda CC, Gut J, Rosenthal PJ, Yardley V, Carvalho de Souza RC, et al. (2006) Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a ‘catch and release’ protocol. Bioorg Med Chem 14: 5605–5615.
[40]
Zhang H, Solomon VR, Hu C, Ulibarri G, Lee H (2008) Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives. Biomedicine & Pharmacotherapy 62: 65–69.
[41]
Trager W, Jensen J (1976) Human malaria parasites in continuous culture. Science 193: 673–675.
[42]
de Andrade-Neto V, Goulart M, da Silva Filho J, da Silva M, Pinto MC, et al. (2004) Antimalarial activity of phenazines from lapachol, beta-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Bioorg Med Chem Lett 14: 1145–1149.
[43]
Lambros C, Vanderberg J (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418–420.
[44]
Xu L, Chaudhuri A (2005) Plasmodium yoelii: a differential fluorescent technique using Acridine Orange to identify infected erythrocytes and reticulocytes in Duffy knockout mouse. Exp Parasitol 110: 80–87.
[45]
Desjardins R, Canfield C, Haynes J, Chulay J (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710–718.
[46]
Andrade-Neto V, Brand？o M, Oliveira F, Casali V, Njaine B, et al. (2004) Antimalarial activity of Bidens pilosa L. (Asteraceae) ethanol extracts from wild plants collected in various localities or plants cultivated in humus soil. Phytother Res 18: 634–639.
[47]
Ncokazi KK, Egan TJ (2005) A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. Anal Biochem 338: 306–319.
[48]
Peters W (1965) Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance. Exp Parasitol 17: 80–89.
[49]
Carvalho L, Brand？o M, Santos-Filho D, Lopes J, Krettli A (1991) Antimalarial activity of crude extracts from Brazilian plants studied in vivo in Plasmodium berghei-infected mice and in vitro against Plasmodium falciparum in culture. Braz J Med Biol Res 24: 1113–1123.
[50]
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271–277.
[51]
Borenfreunda E, Babicha H, Martin-Alguacila N (1987) Comparisons of two in vitro cytotoxicity assays: The neutral red (NR) and tetrazolium MTT tests. Toxicology in vitro 2: 1–6.
[52]
Madureira MC, Martins AP, Gomes M, Paiva J, Proen？a da Cunha A, et al. (2002) Antimalarial activity of medicinal plants used in traditional medicine in S Tomé and Príncipe islands. J. Ethnopharmacol 8: 23–29.
[53]
Wang C, Qin X, Huang B, He F, Zeng C (2010) Hemolysis of human erythrocytes induced by melamine-cyanurate complex. Biochem Biophys Res Commun 402: 773–777.
[54]
Frisch MJ (2003) Gaussian 03, Revision C.02 Gaussian, Inc.
[55]
Thomsen R, Christensen M (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49: 3315–3321.
[56]
Bernstein F, Koetzle T, Williams G, Meyer EJ, Brice M, et al. (1977) The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol 112: 535–542.
[57]
Berman H, Battistuz T, Bhat T, Bluhm W, Bourne P, et al. (2002) The Protein Data Bank. Acta Crystallogr D Biol Crystallogr 58: 899–907.
